SCHEMBL18488343

SCHEMBL18488343

CC(C)c1cc(C=O)ccc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.47
ALDH1A1 P00352 10/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A3 P47895 1/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 1/20 0.38
PTGS2 P35354 1/20 0.38
RAB9A P51151 1/20 0.38
CYP2A6 P11509 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KIF11 P52732 1/20 0.36
HPGD P15428 2/20 0.35
AOX1 Q06278 1/20 0.35
TRIM24 O15164 1/20 0.35
ALDH5A1 P51649 1/20 0.35
ABAT P80404 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TRIM33 Q9UPN9 1/20 0.35
PTGER4 P35408 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29956336 1.00 TYR (0.47) TYRALDH1A1SMN1; SMN2ALDH1A3TSHR
SCHEMBL9945904 0.84 TYR (0.47) TYRALDH1A1SMN1; SMN2ALDH1A3TSHR
SCHEMBL9231758 0.81 TYR (0.52) TYRALDH1A1ALDH1A3TSHRKDM4E
SCHEMBL18488056 0.80 ALDH1A1 (0.39) ALDH1A1TSHRPTGS2TDP1
SCHEMBL18488113 0.80 NFE2L2 (0.33)
SCHEMBL24666654 0.78 TYR (0.45) TYRALDH1A1ALDH1A3TSHRKDM4E
SCHEMBL29820525 0.78 TYR (0.45) TYRALDH1A1ALDH1A3TSHRKDM4E
SCHEMBL23718577 0.78 CNR2 (0.41) TYRALDH1A1TSHRKDM4ERAB9A
SCHEMBL9322668 0.78 TYR (0.48) TYRALDH1A1ALDH1A3TSHRKDM4E
SCHEMBL29818670 0.78 TYR (0.48) TYRALDH1A1SMN1; SMN2ALDH1A3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017023905-A1 HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA BRISTOL-MYERS SQUIBB COMPANY (US) 2017-02-09 WO disclosed